Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) ("Valneva” or the "Company”), a specialty vaccine company, today announces that it has filed a prospectus supplement as part of the renewal of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback